Silence Therapeutics Plc (SLNCF)
1.75
+0.15
(+9.38%)
USD |
OTCM |
Feb 27, 16:00
Silence Therapeutics EPS Diluted (Quarterly) : -0.1479 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Adaptimmune Therapeutics Plc | -0.1163 |
| Biodexa Pharmaceuticals Plc | -- |
| Oxford Biomedica Plc | -- |
| NuCana Plc | -0.1348 |
| Autolus Therapeutics Plc | -0.2954 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -20.96M |
| Revenue (Quarterly) | 0.159M |
| Total Expenses (Quarterly) | 21.12M |
| Enterprise Value | 145.97M |
| Gross Profit Margin (Quarterly) | -12.89% |
| Profit Margin (Quarterly) | -13.18K% |
| Earnings Yield | -45.20% |
| Normalized Earnings Yield | -44.83 |